Alkermes

In News

Clinton County commissioners recognize Alkermes for support of Job & Family Services - Wilmington News Journal

Wilmington News Journal - Oct 14, 2026

Alkermes reinstated Buy at Truist on narcolepsy opportunity - TradingView

TradingView - Oct 16, 2026

With pioneering ADHD data, Alkermes eyes orexin agonist as potential ‘company changer’ - Fierce Biotech

Fierce Biotech - Sep 21, 2026

Sleep Data Might Change The Case For Investing In Alkermes Stock (ALKS) - Simply Wall Street

Simply Wall Street - Oct 14, 2026

Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research - BioSpace

BioSpace - Oct 13, 2026

Truist Securities Reinstates Alkermes (ALKS) Coverage with Buy R - GuruFocus

GuruFocus - Oct 16, 2026

Truist sets USD 55.00 target for Alkermes stock - ad-hoc-news.de

ad-hoc-news.de - Oct 17, 2026

Alkermes to present sleep medicine data at European congress - Investing.com

Investing.com - Oct 13, 2026

Could Alkermes plc (ALKS) Stock Rebound After Investors Look Beyond Near-Term Profit Pressure? - Yahoo Finance

Yahoo Finance - Aug 11, 2026

ALKS Stock Surges 15% On Lilly-Centessa Buyout Igniting Sleep Pipeline Hopes - Stocktwits

Stocktwits - Oct 14, 2026

Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda - BioPharma Dive

BioPharma Dive - Jun 26, 2026

Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial - STAT

STAT - Sep 21, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment